Aliases & Classifications for Rosacea

About this section

Aliases & Descriptions for Rosacea:

Name: Rosacea 11 38 39 13 68
Acne, Erythematosa 11
 
Acne Roscea 11

Classifications:



External Ids:

Disease Ontology11 DOID:8881
ICD1030 L71, L71.9
ICD9CM32 695.3
MeSH39 D012393
NCIt45 C97136

Summaries for Rosacea

About this section
MedlinePlus:38 Rosacea is a long-term disease that affects your skin and sometimes your eyes. it causes redness and pimples. rosacea is most common in women and people with fair skin. it most often affects middle-aged and older adults. in most cases, rosacea only affects the face. symptoms can include frequent redness of the face, or flushing small, red lines under the skin acne a swollen nose thick skin, usually on the forehead, chin, and cheeks red, dry, itchy eyes and sometimes vision problems no one knows what causes rosacea. you may be more likely to have it if you blush a lot or if rosacea runs in your family. rosacea is not dangerous. there is no cure, but treatments can help. they include medicines and sometimes surgery. nih: national institute of arthritis and musculoskeletal and skin diseases

MalaCards based summary: Rosacea, also known as acne, erythematosa, is related to granulomatous rosacea and rosacea conjunctivitis, and has symptoms including exanthema and pruritus. An important gene associated with Rosacea is CAMP (Cathelicidin Antimicrobial Peptide), and among its related pathways are IL1 and megakaryocytes in obesity and Angiogenesis (WikiPathways). The drugs sulfur and loteprednol etabonate have been mentioned in the context of this disorder. Affiliated tissues include skin, eye and small intestine, and related mouse phenotypes are digestive/alimentary and neoplasm.

Wikipedia:71 Rosacea is a long-term skin condition characterized by facial redness, small and superficial dilated... more...

Related Diseases for Rosacea

About this section

Diseases related to Rosacea via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 165)
idRelated DiseaseScoreTop Affiliating Genes
1granulomatous rosacea12.4
2rosacea conjunctivitis11.8
3acne10.4
4aminoaciduria10.2MMP8, MMP9
5dermatitis10.2
6kidney osteogenic sarcoma10.2MMP9, VEGFA
7hepatic vascular disease10.1MMP9, VEGFA
8senile atrophy of choroid10.1MMP9, VEGFA
9microcephaly10.1TLR2, TNF, VDR
10large cell medulloblastoma10.1MMP9, VEGFA
11spotted fever10.1TLR2, TNF
12neonatal hypoxic and ischemic brain injury10.1IL6, MMP9
13vps11-related autosomal recessive hypomyelinating leukodystrophy10.1IL6, TNF
14craniosynostosis, type 110.1IL6, VEGFA
15demodicidosis10.1
16periarthritis10.1TLR2, TNF, VDR
17dyslexia 510.1IL6, TNF
18aortic atherosclerosis10.0IL6, TNF
19stickler syndrome, type v10.0IL6, MMP9, VDR
20fasciitis10.0MMP8, TLR2, TNF
21ulcerative proctitis10.0TLR2, TNF, VEGFA
22unilateral multicystic dysplastic kidney10.0IL6, TNF
23thymic neuroendocrine carcinoma10.0IL6, TNF
24vascular dementia10.0MMP8, MMP9, TNF
25swine influenza10.0IL6, TNF
26drug dependence10.0IL6, TNF
27afibrinogenemia10.0IL6, VDR
28conjugate gaze palsy10.0IL6, TLR2, VEGFA
29cardiac tuberculosis10.0IL6, VEGFA
30labyrinthitis10.0IL6, TNF, VDR
31pituitary infarct10.0IL6, MMP9, VEGFA
32aortic coarctation10.0IL6, TLR2, TNF
33mixed ductal-endocrine carcinoma10.0IL6, MMP8, MMP9
34crohn's colitis10.0IL6, TLR2, TNF
35histiocytoid hemangioma10.0IL6, MMP9, VEGFA
36autoimmune disease of central nervous system10.0IL6, TLR2, TNF
37inappropriate adh syndrome10.0IL6, TLR2, TNF
38disease of mental health10.0IL6, TLR2, TNF
39atrophy of prostate10.0IL6, TLR2, TNF
40trichomalacia10.0IL6, MMP9, TNF
41mansonelliasis10.0IL6, TLR2, TNF
42hallucinogen dependence10.0IL6, TLR2, TNF
43asbestosis10.0IL6, TLR2, TNF
44keratomalacia10.0IL6, TLR2, TNF
45chordoid meningioma9.9IL6, MMP9, TNF
46splenic marginal zone lymphoma9.9IL6, MMP9, TNF
47nephropathy with pretibial epidermolysis bullosa and deafness9.9IL6, TLR2, TNF
48autosomal recessive type iv ehlers-danlos syndrome9.9IL6, MMP8, TNF
49sclerosing adenosis of breast9.9IL6, TLR2, TNF
50placenta praevia9.9MMP9, TNF, VEGFA

Graphical network of the top 20 diseases related to Rosacea:



Diseases related to rosacea

Symptoms & Phenotypes for Rosacea

About this section

UMLS symptoms related to Rosacea:


exanthema, pruritus

MGI Mouse Phenotypes related to Rosacea according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053818.7IL6, MMP9, TLR2, TNF, VDR, VEGFA
2MP:00020068.6IL6, MMP8, MMP9, TLR2, TNF, VEGFA
3MP:00053858.4IL6, MMP9, PTGDR, TLR2, TNF, VDR
4MP:00107718.3IL6, MMP9, PTGDR, TLR2, TNF, VDR
5MP:00053698.3IL6, MMP9, PTGDR, TLR2, TNF, VDR
6MP:00053978.1CAMP, IL6, MMP9, PTGDR, TLR2, TNF
7MP:00053887.9IL6, MMP9, PTGDR, TLR2, TNF, VEGFA
8MP:00053877.6CAMP, IL6, MMP8, MMP9, PTGDR, TLR2

Drugs & Therapeutics for Rosacea

About this section

Drugs for Rosacea (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 134)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Ivermectinapproved, vet_approvedPhase 4, Phase 3, Phase 1, Phase 26170288-86-76474909, 46936176
Synonyms:
(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,8,19-tetramethyl-6'-[(1S)-1-methylpropyl]-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside
22,23-Dihydroxy-avermectin B
22,23-Dihyroavermectin B1
5-O-Demethyl-22,23-dihydro-avermectin A1a
71827-03-7
AB00513813
AC1MJ4GR
AC1N7O27
BPBio1_000322
BRD-K24652731-001-02-7
BSPBio_000292
CHEMBL341047
CID11957587
CID4330618
CID6321424
CID6419971
CID6427057
EU-0100693
FT-0082656
HMS1568O14
 
HMS2089M09
I 8898
I8898_SIGMA
IVERMECTIN
Ivermectin
Ivermectina
Ivermectine
Ivermectinum
Lopac0_000693
MK-933
MLS001333247
MLS001333248
MLS002153248
MolPort-006-394-715
NCGC00094047-01
NCGC00094047-02
NCGC00094047-03
Prestwick2_000156
Prestwick3_000156
Prestwick_516
S1351_Selleck
SMR000857211
2
Doxycyclineapproved, investigational, vet_approvedPhase 4, Phase 3, Phase 2243564-25-054671203
Synonyms:
(2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10597-92-9
17086-28-1 (mono-hydrate)
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)
24390-14-5
41411-66-9 (6-epimer, mono-hydrochloride)
5-Hydroxy-alpha-6-deoxytetracycline
5-hydroxy-α-6-deoxytetracycline
564-25-0
6-Deoxyoxytetracycline
6-Deoxytetracycline
6-alpha-Deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
69935-17-7 (mono-hydrochloride, di-hydrate)
6alpha-Deoxy-5-oxytetracycline
6alpha-deoxy-5-oxytetracycline
6α-deoxy-5-oxytetracycline
7164-70-7
7264-10-0
94088-85-4 (calcium salt (1:2))
AB08 (*Fosfatex)
AC1NQXW7
AC1NS4CW
AC1NUYS8
AC1O8PYM
Alti-Doxycycline
Anhydrous doxycycline
Apo-Doxy
Atridox
Azudoxat
BCBcMAP01_000024
BIDD:GT0146
BMY-28689
BPBio1_000951
BSPBio_000863
BSPBio_001936
BU-3839T
C06973
CHEBI:50845
CHEMBL1433
CID5281011
CID5353597
CID5463943
CID6713981
CPD001550033
D07876
DB00254
DMSC (*Fosfatex)
DOXCYCLINE ANHYDROUS
DOXY
DOXYCYCLINE CALCIUM
DOXYCYCLINE MONOHYDRATE
Deoxymykoin
DivK1c_000345
Dossiciclina
Dossiciclina [DCIT]
Doxcycline anhydrous
Doxiciclina
Doxiciclina [INN-Spanish]
Doxiciclina [Italian]
Doxitard
Doxivetin
Doxy-Caps
Doxy-Puren
Doxy-Tabs
Doxycen
Doxychel
Doxychel (TN)
Doxycin
Doxycyclin
Doxycycline (200mg/day) or Placebo
 
Doxycycline (INN)
Doxycycline (TN)
Doxycycline (anhydrous)
Doxycycline (internal use)
Doxycycline Hyclate
Doxycycline Monohydrate
Doxycycline anhydrous
Doxycycline hyclate
Doxycycline-Chinoin
Doxycyclinum
Doxycyclinum [INN-Latin]
Doxysol
Doxytec
Doxytetracycline
EINECS 209-271-1
GS-3065 (*monohydrate)
HMS2090E06
HSDB 3071
Hydramycin
IDI1_000345
Investin
Jenacyclin
KBio1_000345
KBio2_001287
KBio2_003855
KBio2_006423
KBio3_001156
KBioGR_001133
KBioSS_001287
LS-187766
LS-93868
Liviatin
Lopac0_000405
MolPort-002-507-423
Monodox
Monodox (*monohydrate)
NCGC00161602-01
NCGC00161602-03
NCGC00161602-04
NCGC00167961-01
NCGC00179395-01
NINDS_000345
NSC633557
Novo-Doxylin
Nu-Doxycycline
Oracea
Prestwick0_000852
Prestwick1_000852
Prestwick2_000852
Prestwick3_000852
Ronaxan
SAM002589932
SMP1_000107
SPBio_000246
SPBio_002784
STOCK1N-34341
Spanor
Spectrum2_000143
Spectrum3_000408
Spectrum4_000527
Spectrum5_000947
Spectrum_000807
Supracyclin
UNII-334895S862
UPCMLD-DP021
UPCMLD-DP021:001
Vibra-tabs
Vibramycin
Vibramycin (*monohydrate)
Vibramycin Novum
Vibramycine
Vibravenos
Vivox (*Hyclate)
alpha-6-Deoxy-5-hydroxytetracycline
alpha-6-Deoxyoxytetracycline
alpha-Doxycycline
doxycycline
3
Cyclosporineapproved, investigational, vet_approvedPhase 492279217-60-0, 59865-13-35284373, 6435893
Synonyms:
1c5f
1cyn
30024_FLUKA
30024_SIGMA
59865-13-3
79217-60-0
AC1L1EQW
AC1NQXJE
AC1NR4C4
AC1NUQK3
AC1NUZNC
AC1O5KOG
AC1Q2UDG
Ambap59865-13-3
Ambotz59865-13-3
Antibiotic S 7481F1
BMT-ABA-SAR-MLE-VAL-MLE-ALA-ALA-MLE-MLE-MVA
BMT-ABA-SAR-MLE-VAL-MLE-ALA-DAL-MLE-MLE-MVA
BPBio1_000496
BRD-A64290322-001-01-6
BRD-A69815203-001-04-3
BRD-K13533483-001-03-0
BSPBio_000450
BSPBio_001596
BSPBio_003186
C 3662
C05086
C1832_SIGMA
C3662_SIGMA
C62H111N11O12
CB-01-09 MMX
CHEBI:106343
CHEBI:328305
CHEBI:4031
CHEMBL160
CHEMBL386389
CHEMBL532318
CID2909
CID5280754
CID5284373
CID5458585
CID5497195
CID6435893
CSA
CYCLOSPORIN A (SEE ALSO TRANSGENIC MODEL EVALUATION (CYCLOSPORIN A))
CYCLOSPORIN A, USP
Ciclosporin
Ciclosporin (JP15)
Ciclosporina
Ciclosporine
Ciclosporinum
Cipol N
Cipol-N
Consupren
Consupren S
CsA
CsA & IFN.alpha.
CyA
Cyclokat
Cyclosporin
Cyclosporin A
Cyclosporin A & IFN.alpha.
Cyclosporin A Implant
Cyclosporin A, Tolypocladium inflatum
Cyclosporine (USP)
Cyclosporine A
Cyclosporine [USAN]
D00184
DE-076
DivK1c_000871
EU-0100242
Equoral
GNF-Pf-2808
Gengraf
Gengraf (TN)
HMS1569G12
HMS1791P18
HMS1921L20
HMS1989P18
HMS2089A09
HMS2092F06
HMS502L13
Helv Chim Acta 60: 1568 (1977)
 
I06-0379
I06-0966
IDI1_000871
KBio1_000871
KBio2_000780
KBio2_003348
KBio2_005916
KBio3_002686
KBioGR_001898
KBioSS_000780
LMPK14000003
LS-257
LS-58836
Lopac0_000242
MLS000028376
MLS001333756
MLS002153454
MLS002207033
Mitogard
Modusik-A
MolPort-000-760-988
MolPort-005-934-008
MolPort-006-705-994
NCGC00093704-01
NCGC00093704-02
NCGC00093704-03
NCGC00093704-04
NCGC00093704-05
NCGC00093704-06
NCGC00093704-07
NCGC00093704-08
NCGC00164258-01
NCGC00164258-02
NINDS_000871
NSC290193
Neoplanta
Neoral
Neoral (TN)
NeuroSTAT
Nova-22007
OL 27-400
OL-27400
OLO-400
Papilock
Prestwick2_000435
Prestwick3_000435
Prestwick_731
Pulminiq
Ramihyphin A
Restasis
Restasis (TN)
S-Neoral
S1514_Selleck
SDZ-OXL 400
SMR000058578
SPBio_001467
SPECTRUM1502202
ST-603
Sandimmun
Sandimmun Neoral
Sandimmune
Sandimmune (TN)
Sandimmune, Gengraf, Restasis, Atopica, Sangcya, Cyclosporine
Sang-2000
Sang-35
SangCyA
Sangcya
Sigmasporin
Sigmasporin Microoral
Spectrum2_001484
Spectrum3_001593
Spectrum4_001279
Spectrum5_001628
Spectrum_000300
TRANSGENIC MODEL EVALUATION (CYCLOSPORIN A)
Vekacia
Zyclorin
cyclophorine
cyclosporin A
cyclosporine
from Tolypocladium inflatum (Trichoderma polysporin)
nchembio.184-comp6
nchembio.301-comp5
nchembio.342-comp1
4
MetronidazoleapprovedPhase 4, Phase 3, Phase 2, Phase 1486443-48-14173
Synonyms:
1-(2-hydroxy-1-ethyl)-2-methyl-5-nitroimidazole
1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(beta-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Oxyethyl)-2-methyl-5-nitroimidazole
1-(β-ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(β-hydroxyethyl)-2-methyl-5-nitroimidazole
1-(β-oxyethyl)-2-methyl-5-nitroimidazole
1-Hydroxyethyl-2-methyl-5-nitroimidazole
2-(2-methyl-5-nitroimidazol-1-yl)ethanol
2-Methyl-5-nitro-1-imidazoleethanol
2-Methyl-5-nitroimidazole-1-ethanol
2-methyl-1-(2-hydroxyethyl)-5-nitroimidazole
2-methyl-3-(2-hydroxyethyl)-4-nitroimidazole
2-methyl-5-nitroimidazole-1-ethanol
443-48-1
46461_FLUKA
46461_RIEDEL
69198-10-3 (mono-hydrochloride)
99616-64-5
AB00052046
AC-10556
AC1L1HKS
AC1Q2P2Z
AKOS000269646
APMN
ARONIS24285
Acromona
Anagiardil
Apo-Metronidazole
Arilin
Atrivyl
BAS 02983617
BAY-5360
BCBcMAP01_000184
BIDD:GT0107
BPBio1_000004
BRD-K52020312-001-05-2
BRN 0611683
BSPBio_000002
BSPBio_002031
Bayer 5360
Bexon
Bio-0694
CAS-443-48-1
CB-01-14 MMX
CCRIS 410
CHEBI:39845
CHEBI:6909
CHEMBL137
CID4173
CONT
CPD000058175
Caswell No. 579AA
Clont
D00409
DB00916
Danizol
Deflamon
Deflamon-wirkstoff
DivK1c_000007
EINECS 207-136-1
EPA Pesticide Chemical Code 120401
Efloran
Elyzol
Entizol
Eumin
FLAGYL I.V. RTU IN PLASTIC CONTAINER
Flagemona
Flagesol
Flagil
Flagyl
Flagyl (TN)
Flagyl 375
Flagyl Er
Flagyl I.V.
Flagyl I.V. RTU
Flegyl
Florazole
Fossyol
Giatricol
Ginefla vir
Gineflavir
HMS1568A04
HMS1920N19
HMS2051G07
HMS2090B19
HMS2091F14
HMS500A09
HMS547C19
HSDB 3129
I14-0667
IDI1_000007
IDR-90105
KBio1_000007
KBio2_001515
KBio2_004083
KBio2_006651
KBio3_001531
KBioGR_000559
KBioSS_001515
Klion
Klont
LS-1264
M0924
M1547_SIGMA
M3761_FLUKA
M3761_SIGMA
M9036_SIGMA
METRO I.V
METRONIDAZOLE USP
MLS000028590
MLS000758286
Maybridge1_001999
Meronidal
Methronidazole
Methyl-5-nitroimidazole-1-ethanol
 
Metric
Metric 21
Metro Cream
Metro Gel
Metro I.V.
Metro I.V. In Plastic Container
MetroCream
MetroGel
MetroGel-Vaginal
MetroLotion
Metrodzhil
Metrogel-vaginal (TN)
Metrogyl
Metrolag
Metrolyl
Metromidol
Metronidaz
Metronidazol
Metronidazol [INN-Spanish]
Metronidazole (JP15/USP/INN)
Metronidazole Benzoate
Metronidazole Monohydrochloride
Metronidazole Phosphoester
Metronidazole [USAN:INN:BAN:JAN]
Metronidazole in Plastic Container
Metronidazolo
Metronidazolo [DCIT]
Metronidazolum
Metronidazolum [INN-Latin]
Metrotop
Metrozine
Metryl
Mexibol
Mexibol 'silanes'
MolPort-000-141-892
MolPort-002-502-101
Monagyl
Monasin
NCGC00016446-01
NCGC00016446-02
NCGC00022059-03
NCGC00022059-04
NCGC00022059-05
NCIOpen2_000337
NIDA
NINDS_000007
NSC 50364
NSC 69587
NSC-50364
NSC50364
NSC69587
Nalox
Nidagel
Noritate
Noritate (TN)
Novonidazol
Orvagil
Prestwick0_000081
Prestwick1_000081
Prestwick2_000081
Prestwick3_000081
Prestwick_334
Protostat
RP 8823
RP-8823
Rathimed
Rosased
S1907_Selleck
SAM001247010
SBB041018
SC 10295
SMP1_000189
SMR000058175
SPBio_000666
SPBio_001941
SPECTRUM1500412
STK177359
Sanatrichom
Satric
Spectrum2_000883
Spectrum3_000506
Spectrum4_000060
Spectrum5_001289
Spectrum_001035
Takimetol
Trichazol
Trichex
Tricho cordes
Tricho-gynaedron
Trichocide
Trichomol
Trichomonacid 'pharmachim'
Trichopal
Trichopol
Tricocet
Tricom
Tricowas B
Trikacide
Trikamon
Trikojol
Trikozol
Trimeks
Trivazol
UNII-140QMO216E
Vagilen
Vagimid
Vandazole
Vertisal
WLN: T5N CNJ A2Q B1 ENW
WLN: T5N CNJA2Q B1 ENW
WLN: T6NTJ DQ ANU1- ET5N CNJ A1 BNW
Wagitran
ZERO/004064
ZINC00113442
Zadstat
Zidoval
giniflavir
metronidazole
neo-Tric
5
Azelaic acidapprovedPhase 4, Phase 2, Phase 3, Phase 133123-99-92266
Synonyms:
0C50D8EC-0DB0-4F24-8EFC-2919E1F0D9BF
1,7-Dicarboxyheptane
1,7-Heptanedicarboxylate
1,7-Heptanedicarboxylic acid
1,9-Nonanedioate
1,9-Nonanedioic acid
123-99-9
17265-13-3 (di-hydrochloride salt)
17356-30-8 (mono-hydrochloride salt)
19619-43-3 (unspecified potassium salt)
1tuf
246379_ALDRICH
26776-28-3
27825-99-6 (unspecified hydrochloride salt)
32733-99-6
38900-29-7 (di-lithium salt)
4-02-00-02055 (Beilstein Handbook Reference)
458317_ALDRICH
52457-54-2 (di-potassium salt)
A-9800
A0561
A96150_ALDRICH
AC1L1DAO
AC1Q75FC
AGN-191861
AI3-06299
AKOS000120052
AZ1
AZA
AZELAIC ACID, 95%
Acide azelaique [French]
Acide azélaïque
Acido azelaico
Acido azelaico [Spanish]
Acidum acelaicum
Acidum azelaicum
Acidum azelaicum [Latin]
Anchoate
Anchoic acid
Azalaic Acid
Azalaic acid
Azelaic
Azelaic acid
Azelaic acid (USAN/INN)
Azelaic acid [USAN:INN]
Azelaic acid polyanhydride
Azelaic acid, technical grade
Azelaic polyanhydride
Azelaicacidtech
Azelainic acid
Azelainsaeure
Azelainsäure
Azelate
Azelex
Azelex (TN)
Azleaic Acid
BIDD:GT0315
BRN 1101094
BSPBio_001756
C08261
C9H16O4
CHEBI:48131
CHEMBL1238
CID2266
D03034
DB00548
Dicarboxylic acid C9
DivK1c_000532
EINECS 204-669-1
EU-0100051
Emerox 1110
Emerox 1144
Emery'S L-110
 
Emery's L-110
Finacea
Finacea (TN)
Finevin
HMS1921O11
HMS2092E22
HMS501K14
HSDB 7659
Heptanedicarboxylic acid
I04-0585
IDI1_000532
InChI=1/C9H16O4/c10-8(11)6-4-2-1-3-5-7-9(12)13/h1-7H2,(H,10,11)(H,12,13
KBio1_000532
KBio2_000437
KBio2_003005
KBio2_005573
KBio3_001256
KBioGR_000662
KBioSS_000437
LMFA01170054
LS-22779
Lepargylate
Lepargylic acid
Lopac-246379
Lopac0_000051
MLS000069659
MLS001148615
MolPort-001-779-873
N-Nonanedioate
N-Nonanedioic acid
NCGC00014993-01
NCGC00014993-02
NCGC00014993-09
NCGC00093565-01
NCGC00093565-02
NCGC00093565-03
NCGC00093565-04
NCGC00093565-05
NCGC00093565-06
NCGC00093565-07
NINDS_000532
NONANEDIOIC ACID
NSC 19493
NSC19493
Nonandisaeure
Nonandisäure
Nonanedioate
Nonanedioic acid
Nonanedioic acid azelaic acid
Nonanedioic acid homopolymer
Nonanedioic acid, homopolymer
Poly(azelaic anhydride)
Polyazelaic anhydride
SBB060279
SDCCGMLS-0066619.P001
SH-441
SMR000059164
SPBio_001089
SPECTRUM1500648
STL059432
Skinorem
Skinoren
Spectrum2_000995
Spectrum3_000278
Spectrum4_000401
Spectrum5_001304
Spectrum_000057
UNII-F2VW3D43YT
ZK 62498
ZK-62498
acide azelaique
acidum azelaicum
azelaic acid
n-Nonanedioic acid
Ácido azelaico
6
Miconazoleapproved, investigational, vet_approvedPhase 4370622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
7
SulfacetamideapprovedPhase 43144-80-95320
Synonyms:
127-56-0 (mono-hydrochloride salt, anhydrous)
144-80-9
4-14-00-02662 (Beilstein Handbook Reference)
46770_FLUKA
46770_RIEDEL
A-500
AC-7630
AC1L1K3B
AI3-26837
AKOS000119729
ARONIS022108
Acetocid
Acetosulfamin
Acetosulfamine
Ak-Sulf
Albamine
Albucid
Alesten
BB_SC-5547
BPBio1_000053
BRN 0981718
BSPBio_000047
BSPBio_002773
Bleph-10
Bleph-10 liquifilm
CBChromo1_000180
CBDivE_013934
CCRIS 6273
CHEBI:102525
CHEMBL455
CID5320
CPD000058173
Caswell No. 808A
Cetamide
D05947
DB00634
DivK1c_000227
EINECS 205-640-6
EPA Pesticide Chemical Code 077904
FML-S
Formosulfacetamide
HMS1921A11
HMS2092I13
HMS500L09
I-Sulfacet
I14-13294
IDI1_000227
Isopto cetamide
Isopto-Cetamide
KBio1_000227
KBio2_001464
KBio2_004032
KBio2_006600
KBio3_001993
KBioGR_001691
KBioSS_001464
Klaron
LS-852
MLS000069710
MLS001076499
MolPort-000-900-614
N -Acetylsulfanilamide
N'-Acetylsulfanilamide
N'-acetylsulfanilamide
N(1)-Acetyl-4-aminophenylsulfonamide
N(1)-Acetylsulfanilamide
N(sup 1)-Acetyl-4-aminophenylsulfonamide
N(sup 1)-Acetylsulfanilamide
N(sup1)-Acetylsulfanilamide
N-((4-Aminophenyl)sulfonyl)acetamide
N-((P-Aminophenyl)sulfonyl)acetamide
N-((p-Aminophenyl)sulfonyl)acetamide
N-(4-Aminobenzenesulfonyl)acetamide
N-(4-Aminophenylsulfonyl)acetamide
N-(4-aminophenyl)sulfonylacetamide
N-(P-Aminobenzenesulfonyl)acetamide
N-Acetyl-4-aminobenzenesulfonamide
N-Acetylsulfanilamide
N-Acetylsulfanilamine
N-Sulfanilylacetamide
N-Sulphanilylacetamide
N-[(4-Aminophenyl)sulfonyl]acetamide
N-[(P-Aminophenyl)sulfonyl]acetamide
N-[(p-Aminophenyl)sulfonyl]acetamide
 
N1-Acetylsulfanilamide
NCGC00018242-01
NCGC00021857-03
NCGC00021857-04
NCGC00021857-05
NCIOpen2_002838
NINDS_000227
NSC 63871
NSC63871
OP-Sulfa 30
Oclucid
Ocusulf-10
Ophthacet
Ophthel-S
Oprea1_686524
Oprea1_810285
P-Aminobenzenesulfonacetamide
P-Aminobenzenesulfonoacetamide
Prestwick0_000014
Prestwick1_000014
Prestwick2_000014
Prestwick3_000014
Region
S8627_SIGMA
SAM002554931
SMR000058173
SPBio_001415
SPBio_001968
SPECTRUM1500545
STK068185
SULSTER
Sebizon
Sodium sulamyd
Sodium sulfacetamide
Solfacetamide
Solfacetamide [DCIT]
Spectrum2_001318
Spectrum3_001017
Spectrum4_001146
Spectrum5_001230
Spectrum_000984
Steramide
Steri-Units Sulfacetamide
Sulamyd
Sulf-10
Sulf-15
Sulfacel-15
Sulfacet
Sulfacetamid
Sulfacetamida
Sulfacetamida [INN-Spanish]
Sulfacetamide (USP/INN)
Sulfacetamide Monosodium Salt
Sulfacetamide Sodium Usp
Sulfacetamide [USAN:INN]
Sulfacetamide sodium
Sulfacetamide sodium anhydrous
Sulfacetamidum
Sulfacetamidum [INN-Latin]
Sulfacetimide
Sulfacil
Sulfacyl
Sulfacyl (VAN)
Sulfacylum
Sulfacétamide
Sulfair
Sulfair 15
Sulfair-15
Sulfanilacetamide
Sulfanilazetamid
Sulfanilazetamid [German]
Sulphacetamide
Sulphacetamide sodium
Sulphacetamidum
Sulphasil
Sulten-10
Sultrin
UNII-4965G3J0F5
Urosulfon
Urosulfone
WLN: ZR DSWMV1
ZINC00057500
p-Aminobenzenesulfonacetamide
p-Aminobenzenesulfonoacetamide
sulfacetamide
8
Aminolevulinic acidapprovedPhase 4165106-60-5137
Synonyms:
106-60-5
35BEC718-C970-426A-9859-BF58284C60B4
5-ALA
5-Amino-4-oxo-Pentanoate
5-Amino-4-oxo-Pentanoic acid
5-Amino-4-oxopentanoate
5-Amino-4-oxopentanoic acid
5-Amino-4-oxovalerate
5-Amino-4-oxovaleric acid
5-Amino-Levulinate
5-Amino-Levulinic acid
5-Aminolaevulinate
5-Aminolaevulinic acid
5-Aminolevulinate
5-Aminolevulinic acid
5-amino-levulinate
5451-09-2
AC-054
AC1L18K9
AKOS003587520
ALA
ALA-PDT
Aladerm
Amino-levulinic acid
Aminolevulinate
Aminolevulinic
Aminolevulinic acid
BIDD:GT0260
BSPBio_003407
C00430
CCRIS 8958
CHEBI:17549
CHEMBL601
CID137
CPD000857229
 
D07567
DALA
DB00855
DivK1c_006954
EINECS 203-414-1
I14-10101
KBio1_001898
KBio2_002062
KBio2_004630
KBio2_007198
KBio3_002627
KBioGR_001176
KBioSS_002062
Kerastick
LMFA01100055
LS-101793
Levulinic acid, 5-amino- (8CI)
MLS001333097
MLS001333098
MolPort-001-788-423
NCGC00178086-01
Pentanoic acid, 5-amino-4-oxo- (9CI)
SAM002589919
SMR000857229
SPBio_001843
ST50819610
SpecPlus_000858
Spectrum2_001662
Spectrum3_001654
Spectrum4_000618
Spectrum5_001505
Spectrum_001582
UNII-88755TAZ87
delta-ALA
delta-Aminolevulinate
delta-Aminolevulinic acid
delta-aminolevulinic acid
9
TimololapprovedPhase 4, Phase 125226839-75-833624, 5478
Synonyms:
(-)-3-Morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole
(2S)-1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(2S)-1-[(1,1-dimethylethyl)amino]-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(S)-1-(1,1-(Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
(S)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol
(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(S)-timolol
131628-37-0
194288-09-0
26839-75-8
26921-17-5 (maleate (1:1) salt)
AB00513729
AC1L1PYN
AC1Q59QM
Apo-Timol
Apo-Timop
Aquanil
BIDD:GT0073
BPBio1_001008
BRD-K08806317-050-03-6
BSPBio_000916
Betim
Betimol
Betimol (TN)
Blocadren
C07141
C13H24N4O3S
CAS-26921-17-5
CHEBI:9599
CHEMBL499
CID33624
CPD001456519
D08600
DB00373
DB08625
EINECS 248-032-6
HMS2089I11
HSDB 6533
Istalol
L-714,465
LS-122231
Lopac-T-6394
Lopac0_001189
MK-950
NCGC00016038-01
 
NCGC00016038-02
NCGC00016798-01
NCGC00016798-07
NCGC00022033-02
NCGC00022033-04
NCGC00022033-05
Novo-Timol
Nu-Timolol
Oprea1_640981
Optimol
Phoxal-timolol
Prestwick0_000948
Prestwick1_000948
Prestwick2_000948
Prestwick3_000948
Proflax
S(-)-Timolol maleate
S-(-)-3-(3-tert-Butylamino-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole
SAM002564238
SPBio_003075
ST072193
TIM
Temserin
Tenopt
Tim-AK
Timacar
Timacor
Timolol
Timolol (INN)
Timolol (TN)
Timolol GFS
Timolol Maleate, (1:1) Salt
Timolol [USAN]
Timolol anhydrous
Timolol maleate
Timololo
Timololum
Timololum [INN-Latin]
Timopic
Timoptic
Timoptic OcuDose
Timoptic in Ocudose
Timoptic-XE
Timoptol
Tocris-0649
UNII-817W3C6175
timolol
10Pharmaceutical SolutionsPhase 4, Phase 1, Phase 2, Early Phase 18192
11Anti-Bacterial AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 111226
12Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 118340
13Antiprotozoal AgentsPhase 4, Phase 3, Phase 2, Phase 12051
14Antiparasitic AgentsPhase 4, Phase 3, Phase 2, Phase 12199
15Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 122062
16AntimalarialsPhase 4, Phase 3, Phase 21246
17Immunosuppressive AgentsPhase 4, Phase 213086
18Anti-Inflammatory AgentsPhase 4, Phase 210729
19Photosensitizing AgentsPhase 4492
20Adrenergic AgentsPhase 4, Phase 3, Phase 2, Phase 15352
21Calcineurin InhibitorsPhase 4, Phase 21622
22Adrenergic alpha-2 Receptor AgonistsPhase 4, Phase 3, Phase 2, Phase 1980
23Adrenergic alpha-AgonistsPhase 4, Phase 3, Phase 2, Phase 11734
24Antihypertensive AgentsPhase 4, Phase 3, Phase 2, Phase 14207
25Dermatologic AgentsPhase 4, Phase 2, Phase 3, Phase 15806
26Adrenergic AgonistsPhase 4, Phase 3, Phase 2, Phase 13027
27Antirheumatic AgentsPhase 4, Phase 2, Phase 110956
28Antifungal AgentsPhase 43696
29Brimonidine TartratePhase 4, Phase 3, Phase 2, Phase 112570359-46-5
30Anti-Arrhythmia AgentsPhase 4, Phase 13093
31Adrenergic beta-AntagonistsPhase 4, Phase 11193
32Adrenergic AntagonistsPhase 4, Phase 11573
33
OxymetazolineapprovedPhase 34551491-59-44636
Synonyms:
1491-59-4
2-(4-Tert-butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline
2-(4-tert-Butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline
3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-6-tert-butyl-phenol
3-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol
3-[(4,5-dihydro-1H-Imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol
6-Tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-tert-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol
6-tert-Butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol
AC-6370
AC1L1IM1
Afrin Cherry 12 Hour Nasal Spray
Afrin Extra Moisturizing 12 Hour Nasal Spray
Afrin Original 12 Hour Nasal Spray
Afrin Original 12 Hour Nose Drops
Afrin Original 12 Hour Pump Mist
Afrin Sinus 12 Hour Nasal Spray
BPBio1_000295
BPBio1_000419
BRD-K16195444-001-01-7
BRN 0886303
BSPBio_000267
BSPBio_002145
Biomol-NT_000161
C07363
CAS-151615
CHEBI:142520
CHEMBL762
CID4636
D010109
D08322
DB00935
DivK1c_000567
Dristan Long Lasting Mentholated Nasal Spray
Dristan Long Lasting Nasal Mist
Drixoral Nasal Solution
Duramist Plus Up To 12 Hour Nasal Decongestant Spray
EINECS 216-079-1
FT-0082560
Genasal Nasal Spray Up to 12 Hour Relief
H 990
HMS2089G03
HSDB 3143
Hazol
IDI1_000567
Iliadin
KBio1_000567
KBio2_001531
KBio2_004099
KBio2_006667
KBio3_001645
KBioGR_000908
KBioSS_001531
L000459
LS-104146
 
Lopac-O-2378
Lopac0_000903
MolPort-002-538-313
NCGC00015766-01
NCGC00015766-02
NCGC00015766-03
NCGC00015766-10
NCGC00022345-02
NCGC00022345-04
NCGC00022345-05
NCGC00022345-06
NINDS_000567
Nafrine
Nasal Relief 12 Hour Nasal Spray
Navasin
Navisin
Neo-Synephrine 12 Hour Spray
Nezeril
Nostrilla 12 Hour Nasal Decongestant
Operil (TN)
Oximetazolina
Oximetazolina [INN-Spanish]
Oximetazolinum
Oxylazine
Oxymetazolina
Oxymetazoline (INN)
Oxymetazoline [INN:BAN]
Oxymetazoline hydrochloride crystalline
Oxymetazolinum
Oxymetazolinum [INN-Latin]
Oxymethazoline
Oxymetozoline
Phenol, 3-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethyl- (9CI)
Phenol, 6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethyl- (7CI,8CI)
Prestwick0_000224
Prestwick1_000224
Prestwick2_000224
Prestwick3_000224
Rhinofrenol
Rhinolitan
SPBio_001095
SPBio_002188
Sinerol
Spectrum2_000998
Spectrum3_000533
Spectrum4_000464
Spectrum5_001114
Spectrum_001051
Tocris-1142
UNII-8VLN5B44ZY
Vicks Sinex 12 Hour Nasal Spray
Vicks Sinex 12 Hour Ultra Fine Mist for Sinus Relief
Visine L.R
Visine L.R.
nchembio705-11
oxymeta zoline
oxymetazoline
oxymetazoline hydrochloride crystalline
34
EphedrineapprovedPhase 3, Phase 1, Phase 2628299-42-39294
Synonyms:
( )-Pseudoephedrine
(+)-Ephedrin
(+)-Ephedrine
(+)-Pseudoephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(+-)-Ephedrine
(-)-Ephedrine
(-)-Pseudoephedrine
(-)-psi-Ephedrine
(-)-threo-Ephedrine
(1R,2R)-Ephedrine
(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane
(1S,2R)-Ephedrine
(L)-EPHEDRINE
--EPHEDRINE
1-EPHEDRINE
1-Sedrin
134910_ALDRICH
287636_ALDRICH
287644_ALDRICH
299-42-3
304-87-0
30987-59-8
321-96-0
321-97-1
321-98-2
37577-31-4
38732-95-5
45261_FLUKA
4607-45-8
50-98-6
50906-05-3
53214-57-6
649031_ALDRICH
6912-63-6
7009-81-6
90-82-4
968-63-8
AC-20231
AC-20292
AC1L1JGK
AC1L1NUA
AC1L1RFA
AC1L1SR1
AC1L1T31
AC1L1Y3M
AC1O8JUO
AC1Q3XJE
AC1Q3XJM
AC1Q3XJN
AC1Q59F5
AC1Q7701
AI3-02761
AKOS000268842
AR-1A0126
AR-1I7143
Acunaso
Acunaso (TN)
Afrinol
Ambap299-42-3
BIDD:GT0817
BRN 3197916
BRN 4231286
BSPBio_001946
BSPBio_001968
BSPBio_003261
Benylin Decongestant
Besan
Biophedrin
C01575
C02765
C10H15NO
CHEBI:15407
CHEBI:51209
CHEMBL1590
CHEMBL211456
CHEMBL357080
CID11972440
CID5032
CID62946
CID6710657
CID7028
CID8650
CID9294
CID9457
CPD-9954
CPDD 0049
Cenafed
D00124
D08449
DB00852
DB01364
Decofed
DivK1c_000181
DivK1c_000451
DivK1c_000461
Drixoral N.D.
EINECS 202-017-0
EINECS 202-018-6
EINECS 206-080-5
EINECS 206-292-8
EINECS 206-293-3
Eciphin
Efedrin
Efidac/24
Eltor 120
Ephedral
Ephedremal
Ephedrin
Ephedrine
Ephedrine (TN)
Ephedrine (USP)
Ephedrine [USAN:BAN]
Ephedrine l-form
Ephedrital
Ephedrol
Ephedrosan
Ephedrotal
Ephedsol
Ephendronal
Ephoxamin
Fedrin
Genaphed
HSDB 3072
HSDB 3177
I-Sedrin
I01-3584
I01-8925
I01-8928
 
IDI1_000181
IDI1_000451
IDI1_000461
Isoephedrine
Jsp005664
KBio1_000181
KBio1_000451
KBio1_000461
KBio2_001358
KBio2_001500
KBio2_003926
KBio2_004068
KBio2_006494
KBio2_006636
KBio3_001188
KBio3_001446
KBio3_002762
KBioGR_001013
KBioGR_001763
KBioSS_001358
KBioSS_001500
KST-1A9168
Kratedyn
L(+)-psi-Ephedrine
L(-)-Ephedrine
L-(+)-Ephedrine
L-(-)-Ephedrine
L-Ephedrine
L-erythro-2-(Methylamino)-1-phenylpropan-1-ol
L000968
LS-125921
LS-125922
LS-43083
LS-63961
LS-63962
LS-63963
LS-63964
Lexofedrin
Lopac-E-3250
Lopac0_000501
MLS000069657
Manadrin
Mandrin
Maxenal
MolPort-001-684-474
MolPort-001-684-477
MolPort-001-684-478
MolPort-001-684-479
MolPort-001-769-085
Myfedrine
NCGC00015408-01
NCGC00015408-02
NCGC00162174-01
NCGC00178180-01
NCGC00178889-01
NCI-C55652
NCI60_002955
NINDS_000181
NINDS_000451
NINDS_000461
NSC 165609
NSC 170951
NSC 8971
NSC165609
NSC170951
NSC8971
Nasol
Neodurasina
Neodurasina (TN)
Oprea1_287330
PDSP1_000168
PDSP1_001106
PDSP1_001343
PDSP1_001345
PDSP1_001346
PDSP1_001347
PDSP2_000167
PDSP2_001090
PDSP2_001327
PDSP2_001329
PDSP2_001330
PDSP2_001331
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoephedrine (D)
Pseudoephedrinum
Psi-ephedrin
Psi-ephedrine
Robidrine
SMR000059174
SPBio_000214
SPBio_001365
SPBio_001377
ST023802
STK367993
STOCK1N-42675
Sanedrine
Spectrum2_000137
Spectrum2_001303
Spectrum2_001309
Spectrum3_000414
Spectrum3_000563
Spectrum3_001771
Spectrum4_000497
Spectrum4_001162
Spectrum5_000650
Spectrum5_000879
Spectrum5_001106
Spectrum_000878
Spectrum_001020
Sudafed
Sudafed Decongestant
UNII-03VRY66076
UNII-7CUC9DDI9F
UNII-GN83C131XS
Vencipon
WLN: QYR & Y1 & M1
WLN: QYR&Y1&M1
Zephrol
d-Ephedrine
d-Isoephedrine
d-Pseudoephedrine
d-psi-Ephedrine
l-Ephedrine
l-Pseudoephedrine
racephedrine
trans-Ephedrine
35
PseudoephedrineapprovedPhase 3, Phase 1, Phase 262890-82-47028
Synonyms:
( )-Pseudoephedrine
(+) threo-2-(methylamino)-1-phenyl-1-propanol
(+)-(1S,2S)-Pseudoephedrine
(+)-Pseudoephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(1S,2S)-(+)-Pseudoephedrine
(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol
(1S,2S)-2-Methylamino-1-phenyl-1-propanol
(1S,2S)-Pseudoephedrine
(1S,2S)-Pseudoephedrine, polymer-bound
1-Ephedrine
2-(Methylamino)-1-phenyl-1-propanol
287636_ALDRICH
304-87-0
30987-59-8
37577-31-4
649031_ALDRICH
90-82-4
AC-20292
AC1L1NUA
Acunaso
Acunaso (TN)
Afrinol
BIDD:GT0817
BRD-K84175871-003-02-2
BSPBio_003261
Balminil Decongestant Syrup
Benylin Decongestant
Benzenemethanol, alpha-((1S)-1-(methylamino)ethyl)-, (alpha-S)- (9CI)
Besan
C02765
C10H15NO
CHEBI:51209
CHEMBL1590
CID7028
CPD-9954
Cenafed
D-Isoephedrine
D-Pseudoephedrine
D-Pseudoephedrine base
D-Psi-2-Methylamino-1-phenyl-1-propanol
D-Psi-Ephedrine
D08449
DB00852
Decofed
Dimetapp Decongestant
Dimetapp Decongestant Pediatric Drops
DivK1c_000451
Drixoral N.D.
Drixoral Nasal Decongestant
EINECS 202-018-6
Efidac 24 Pseudoephedrine Hcl
Efidac/24
Eltor 120
Ephedrine
Genaphed
HSDB 3177
I01-8928
IDI1_000451
Isoephedrine
KBio1_000451
 
KBio2_001358
KBio2_003926
KBio2_006494
KBio3_002762
KBioGR_001763
KBioSS_001358
L(+)-Psi-Ephedrine
L(+)-psi-Ephedrine
L-(+)-Pseudoephedrine
LS-125922
Lopac-E-3250
Maxenal
MolPort-001-684-474
Myfedrine
NCGC00015408-01
NCGC00178180-01
NCI60_002955
NINDS_000451
Neodurasina
Neodurasina (TN)
Novafed
PDSP1_001347
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoefedrina [INN-Spanish]
Pseudoephedrine
Pseudoephedrine (D)
Pseudoephedrine (INN)
Pseudoephedrine D-form
Pseudoephedrine Ephedrine
Pseudoephedrine [INN:BAN]
Pseudoephedrine d-form
Pseudoephedrinum
Pseudoephedrinum [INN-Latin]
Psi-ephedrin
Psi-ephedrine
Robidrine
SPBio_001365
STOCK1N-42675
Spectrum2_001303
Spectrum3_001771
Spectrum4_001162
Spectrum5_000650
Spectrum_000878
Sudafed
Sudafed Decongestant
Sudafed Decongestant 12 Hour
Sudafed Decongestant Extra Strength
Triaminic AM Decongestant Formula
Triaminic Infant Oral Decongestant Drops
UNII-7CUC9DDI9F
alpha-(1-(Methylamino)ethyl)benzyl alcohol
d-Isoephedrine
d-Pseudoephedrine
d-psi-2-Methylamino-1-phenyl-1-propanol
d-psi-Ephedrine
pseudoéphédrine
trans-Ephedrine
ψ-ephedrine
36
Minocyclineapproved, investigationalPhase 3, Phase 2, Phase 123110118-90-85281021
Synonyms:
(2Z,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE
(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10118-90-8
13614-98-7 (mono-hydrochloride)
4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
4708-96-7
7-Dimethylamino-6-demethyl-6-deoxytetracycline
AC1NQXWM
Alti-Minocycline
Apo-Minocycline
Arestin
BRN 3077644
Bio-0062
Borymycin
C07225
C23H27N3O7
CHEBI:50694
CHEBI:529981
CHEMBL1434
CHEMBL259172
CID5281021
CL 59806
CRL-1605 & Minocycline
D05045
Dynacin
Gen-Minocycline
HMS2090D03
HSDB 3130
Klinomycin
 
LMPK07000002
LS-93850
Lactoferrin B & Minocycline
Lactoferrin H & Minocycline
MINO
MIY
Minociclina
Minociclina [INN-Spanish]
Minociclinum
Minocin
Minocin (Hydrochloride)
Minocline
Minocyclin
Minocycline (USAN/INN)
Minocycline HCl
Minocycline Monohydrochloride
Minocycline [USAN:BAN:INN]
Minocyclinum
Minocyclinum [INN-Latin]
Minocyn
Minomycin
NCGC00178854-01
NSC 141993
NSC141993
Novo-Minocycline
Solodyn
UNII-FYY3R43WGO
Vectrin
Vectrin (Hydrochloride)
minociclinum
minocycline
nchembio.559-comp1
37
IsotretinoinapprovedPhase 31244759-48-25538, 5282379
Synonyms:
(13-cis)-Retinoate
(13-cis)-Retinoic acid
(13cis)-retinoic acid
(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
(2Z,4E6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid
(7E,9E,11E,13Z)-retinoic acid
(7e,9e,11e,13Z)-Retinoic acid
13 Cis-Retinoic Acid
13 cis retinoic acid
13-RA
13-cis RA
13-cis retinoic acid
13-cis-Retinoate
13-cis-Retinoic acid
13-cis-Vitamin A acid
13-cis-Vitamin a acid
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-cis-4-trans-6-trans-8-trans-nonatetraenoic acid
4-09-00-02388 (Beilstein Handbook Reference)
4759-48-2
97950-17-9
AC-15388
AC1NQZZ4
Accutane
Accutane (TN)
Ambap302-79-4
Amnesteem
BML2-E07
BPBio1_000080
BRD-K76723084-001-05-9
BRN 1885770
BSPBio_000072
BSPBio_001331
BSPBio_003345
CCRIS 4286
CHEBI:6067
CHEMBL547
CID5282379
CIP-Isotretinoin
CPD000471891
Claravis
D00348
D015474
EINECS 225-296-0
EU-0101081
HMS1361C13
HMS1568D14
HMS1791C13
HMS1921D08
HMS1989C13
HMS2092N07
HSDB 3929
IDI1_033801
Isotane
Isotretinoin
Isotretinoin (USP)
Isotretinoin Retinoic acid
 
Isotretinoin Zinc Salt, 13 cis Isomer
Isotretinoin Zinc Salt, 13-cis-Isomer
Isotretinoin [USAN:BAN:INN]
Isotretinoin [USAN:INN:BAN]
Isotretinoina
Isotretinoine
Isotretinoine [INN-French]
Isotretinoino
Isotretinoino [INN-Spanish]
Isotretinoinum
Isotretinoinum [INN-Latin]
Isotrex
LMPR01090021
LS-143465
Lopac0_001081
MLS001074662
MolPort-003-666-394
NCGC00094358-01
NCGC00094358-02
NCGC00094358-03
NCGC00094358-04
NCGC00094358-05
NCGC00094358-06
NCGC00094358-07
NCGC00094358-08
NCGC00094358-09
NCGC00094358-13
Neovitamin A acid
Neovitamin a acid
Prestwick2_000256
Prestwick3_000256
Prestwick_642
R 3255
R3255_SIGMA
Retinoate
Retinoic acid
Ro 4 3780
Ro 4-3780
Ro 43780
Ro-4-3780
Ro-43780
Roaccutan
Roaccutane
Roacutan
SAM002548955
SMR000471891
SPECTRUM1502013
Sotret
Sotret (TN)
Spectrum5_001795
Spectrum5_001937
Teriosal
UNII-EH28UP18IF
cis-RA
cis-Retinoate
cis-Retinoic acid
isotretinoino
38
BenzocaineapprovedPhase 320161994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Caswell No. 430A
Chloraseptic
D001566
D00552
DB01086
Dermoplast
Diet Ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
 
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Formate, Benzocaine
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
MLS001331704
MLS002153970
Methanesulfonate, Benzocaine
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Norcain
Norcaine
Norcainum
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orthesin
Otocain
Outgro
Parathesin
Parathesin (TN)
Parathesine
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
39
PhenylephrineapprovedPhase 345559-42-76041
Synonyms:
(-)-m-Hydroxy-alpha-(methylaminomethyl)benzyl alcohol
(-)-m-Hydroxy-α-(methylaminomethyl)benzyl alcohol
(R)-2-Hydroxy-2-(3-hydroxyphenyl)-N-methylethylamine
(R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol
1416-03-1
3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol
59-42-7
61-76-7 (hydrochloride)
AC1L1LO9
AC1Q40UF
AI3-02402
AK-Dilate
AK-Nefrin
Adrianol
Ah-Chew
Ak-Dilate
Ak-Nefrin
Ak-dilate
Ak-nefrin
Alcon Efrin
Alcon efrin
Alconefrin Nasal Drops 12
Alconefrin Nasal Drops 25
Alconefrin Nasal Drops 50
Alconefrin Nasal Spray 25
BIDD:GT0157
BSPBio_002420
Benzenemethanol, 3-hydroxy-alpha-((methylamino)methyl)-, (R)- (9CI)
Biomydrin
C07441
CCRIS 8464
CHEBI:8093
CHEMBL1215
CID6041
Cyclomydril
D08365
DB00388
Dilatair
Dimetane
Dionephrine
DivK1c_000597
Doktors
Duration
EINECS 200-424-8
EINECS 215-810-1
Fenilefrina
Fenilefrina [INN-Spanish]
HSDB 3383
I-Phrine
IDI1_000597
Isophrim
Isophrin
Isopto Frin
KBio1_000597
KBio2_001581
KBio2_004149
KBio2_006717
KBio3_001640
KBioGR_001313
KBioSS_001581
L-Phenylephedrine
L-Phenylephrine
LS-43027
Lopac-P-6126
Lopac0_000920
M-Methylaminoethanolphenol
M-Oxedrine
M-Sympathol
M-Sympatol
M-Synephrine
 
Mesaton
Mesatone
Mesatonum
Metaoxedrin
Metaoxedrine
Metaoxedrinum
Metasympatol
Metasynephrine
Metsatonum
Mezaton
Minims Phenylephrine
MolPort-001-792-191
Mydfrin
NCGC00015825-01
NCGC00015825-02
NCGC00024257-03
NCGC00024257-05
NCGC00024257-06
NINDS_000597
Neo-Synephrine
Neo-Synephrine Nasal Drops
Neo-Synephrine Nasal Jelly
Neo-Synephrine Nasal Spray
Neo-Synephrine Pediatric Nasal Drops
Neofrin
Neophryn
Neosynephrine
Nostril
Nostril Spray Pump
Nostril Spray Pump Mild
Ocu-Phrin Sterile Eye Drops
Ocu-Phrin Sterile Ophthalmic Solution
Ocugestrin
P0395
PDSP1_001108
PDSP2_001092
Phenoptic
Phenylephrine
Phenylephrine (INN)
Phenylephrine Minims
Phenylephrine Minims (TN)
Phenylephrine [INN:BAN]
Phenylephrinum
Phenylephrinum [INN-Latin]
Prefrin
Prefrin Liquifilm
Pyracort D
R(-)-Mezaton
R(-)-Phenylephrine
Relief Eye Drops for Red Eyes
Rhinall
SPBio_001280
Spectrum2_001280
Spectrum3_000770
Spectrum4_000967
Spectrum5_001411
Spectrum_001101
Spersaphrine
Tannins, compds. with (R)-3-hydroxy-alpha-((methylamino)methyl)benzenemethanol
UNII-1WS297W6MV
Vicks Sinex
Visadron
l-(3-Hydroxyphenyl)-N-methylethanolamine
l-1-(m-Hydroxyphenyl)-2-methylaminoethanol
l-alpha-Hydroxy-beta-methylamino-3-hydroxy-L-ethylbenzene
l-m-Hydroxy-alpha-((methylamino)methyl)benzyl alcohol
m-Methylaminoethanolphenol
m-Oxedrine
m-Sympathol
m-Sympatol
m-Synephrine
phenylephrine
40
Clindamycinapproved, vet_approvedPhase 2, Phase 317218323-44-929029
Synonyms:
13441-63-9
16669-21-9
18323-44-9
21462-39-5 (mono-hydrochloride)
24620-78-8
24696-19-3
58207-19-5
7(S)-Chloro-7-deoxylincomycin
7-CDL
7-Chloro-7-deoxylincomycin
7-Chlorolincomycin
7-Deoxy-7(S)-chlorolincomycin
AC1L1EGQ
AC1L1GLA
AC1L9JV8
AC1MHD7N
AC1MHE1M
AC1MHUOE
AC1MHX4G
AC1NWAKO
AC1O7ENS
AC1O7GED
AC1OFCIP
AC1OFCIV
AC1OFCJ1
AC1OFCJ7
AC1OIBYJ
AC1OIBYL
AC1OIBYN
AC1Q2V4O
Antirobe
BIDD:GT0418
BPBio1_000236
BRD-A23034328-003-03-4
BSPBio_000214
BSPBio_002049
C06914
C18H33ClN2O5S
CAS-21462-39-5
CHEBI:3745
CHEMBL187
CID2786
CID29029
CID3000512
CID3001928
CID3032758
CID3034218
CID446598
CID5702026
CID6602476
CID6604361
CID7048642
CID7048644
CID7048646
CID7048648
CID7276014
CID7276016
CID7276018
CID9812677
CLDM
CLINDA & IL-12
CLY
Chlolincocin
Chlorlincocin
Chlorodeoxylincomycin
Chlorolincomycin
Cleocin
Cleocin (TN)
Cleocin (tn)
Cleocin HCl
Cleocin Hcl
Cleocin Pediatric
Cleocin Phosphate
Cleocin T
Cleocin T Gel
Cleocin T Lotion
Cleocin T Topical Solution
 
Clinda-Derm
ClindaDerm
Clindagel
Clindamicina
Clindamicina [INN-Spanish]
Clindamycin
Clindamycin & Interleukin 12
Clindamycin & VRC3375
Clindamycin (USAN/INN)
Clindamycin Hcl
Clindamycin Hydrochloride
Clindamycin Phosphate
Clindamycin [USAN:BAN:INN]
Clindamycine
Clindamycine [French]
Clindamycine [INN-French]
Clindamycinum
Clindamycinum [INN-Latin]
Clindesse
Clindets
Clinimycin
D00277
DB01190
Dalacin
Dalacin C
Dalacin C Flavored Granules
Dalacin C Phosphate
Dalacin T Topical Solution
Dalacine
DivK1c_000464
EINECS 242-209-1
Evoclin
HMS2089A05
HMS2089N16
HSDB 3037
I06-0826
IDI1_000464
KBio1_000464
KBio2_000638
KBio2_003206
KBio2_005774
KBio3_001269
KBioGR_000844
KBioSS_000638
Klimicin
Klindan 300
LS-187128
LS-98131
MLS001183714
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside
MolPort-002-323-206
MolPort-002-964-479
NCGC00016752-01
NCGC00178843-01
NCGC00179636-01
NINDS_000464
Prestwick0_000137
Prestwick1_000137
Prestwick2_000137
Prestwick3_000137
ResiDerm A
SMP2_000295
SMR000677917
SPBio_000670
SPBio_002153
STK177246
STOCK1N-31150
Sobelin
Spectrum2_000885
Spectrum3_000355
Spectrum4_000292
Spectrum5_001525
Spectrum_000158
U 21251
U-21,251
U-21251
UNII-3U02EL437C
Zindaclin
clindamycin
41tannic acidapproved, NutraceuticalPhase 32016
42
Tretinoinapproved, investigational, nutraceuticalPhase 2, Phase 3228302-79-45538
Synonyms:
(all-e)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
.beta.-Retinoic acid
13497-05-7 (hydrochloride salt)
15-Apo-beta-caroten-15-oic acid
187175-63-9
1n4h
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4,6,8-nonatetraenoic acid (ecl)
302-79-4
5300-03-8
56573-65-0
7005-78-9
9(Z)-Retinoic acid
9-cis-RA
A-Acido (Argentina)
A-Vitaminsyre
A-Vitaminsyre [Denmark]
AC-6824
AC1L9GWO
AC1Q1J2J
AGN 100335
AGN 192013
AKOS000280845
ALRT 1057
AT-RA
ATRA
Aberel
Aberela
Aberela [Norway]
Accutane Roche
Acid A Vit (Belgium, Netherlands)
Acid, Retinoic
Acid, Vitamin A
Acid, all-trans-Retinoic
Acid, beta-all-trans-Retinoic
Acid, trans-Retinoic
Acide retinoique (French) (DSL)
Acide retinoique (french) (dsl)
Acnavit
Acnavit [Denmark]
Airol
Aknefug
Aknoten
Alitretinoin
All Trans Retinoic Acid
All Trans-Retinoic Acid
All-trans Retinoic Acid
Alltrans-retinoic acid
Amnesteem
Atra-IV
Atragen
Atralin
Avita (TN)
Avita Gel
Avitoin
Avitoin [Norway]
BAL4079
BIDD:GT0483
BIDD:PXR0081
BML2-E05
BPBio1_000082
BRN 2057223
BSPBio_000074
BSPBio_001500
Betarretin
C00777
CCRIS 3294
CCRIS 7098
CHEBI:15367
CHEMBL38
CID444795
CPD000058245
Claravis
Cordes VAS [Germany]
Cordes vas
D00094
D014212
DB00523
DB00755
DB00982
Dermairol
EINECS 206-129-0
EU-0101061
Effederm
Effederm [France]
Epi-aberel
Eudyna
HMS1361K22
HMS1568D16
HMS1791K22
HMS1921D14
HMS1989K22
HMS2089D20
HMS2092N11
HMS502N05
HSDB 2169
HSDB 7186
I04-0008
I14-2351
IDI1_000903
IDI1_033970
Isotretinoin Retinoic acid
L000833
LGD 100057
LMPR01090019
LS-1154
Lopac0_001061
Lsotretinoin
MLS000028588
MLS001076515
MLS002207234
MLS002222211
MolPort-000-883-857
NCGC00017280-06
NCGC00017280-17
NCGC00021808-04
 
NCGC00021808-05
NCGC00021808-06
NCGC00021808-07
NCGC00021808-09
NCGC00021808-14
NCGC00021808-15
NSC 122758
NSC-122758
NSC122758
Nexret
PDT-002-002
Panretin Gel
Panretyn
Potassium Salt, Tretinoin
Prestwick2_000257
Prestwick3_000257
Prestwick_424
R 2625
R0064
R2625_SIGMA
REA
RETINOIC ACID, ALL TRANS
RETINOIC acid
Renova
Renova (TN)
Retacnyl
Retin A
Retin A (TN)
Retin-A
Retin-A Micro
Retin-a
Retinoate
Retinoic acid
Retinoic acid, all-trans- (8CI)
Retinova
Retionic Acid
Retionic acid
Retisol-A
Retisol-a
Ro 1-5488
S1653_Selleck
SAM002264647
SMR000058245
SPECTRUM1502016
SR-01000000239
SR-01000000239-14
ST057075
Salt, Tretinoin Potassium
Salt, Tretinoin Sodium
Salt, Tretinoin Zinc
Sodium Salt, Tretinoin
Solage
Sotret
Spectrum5_001746
Spectrum5_001933
Stieva-A
Stieva-a
Stieva-a Forte
TRETINON
Tretin M
Tretin m
Tretinoin
Tretinoin (JAN/USP/INN)
Tretinoin (TN)
Tretinoin 0.1% cream or placebo
Tretinoin Potassium Salt
Tretinoin Sodium Salt
Tretinoin Zinc Salt
Tretinoin [USAN:INN:BAN]
Tretinoin/All-Trans Retinoic Acid
Tretinoina
Tretinoina [INN-Spanish]
Tretinoine
Tretinoine (french) (einecs)
Tretinoine [INN-French]
Tretinoino
Tretinoino [INN-Spanish]
Tretinoinum
Tretinoinum [INN-Latin]
Tri-Luma
Trétinoïne
UNII-1UA8E65KDZ
UNII-5688UTC01R
UPCMLD-DP097
Vesanoid
Vesanoid (TN)
Vesanoid, Airol, Renova, Atralin, Retin-A, Avita, Tretinoin
Vesnaroid
Vitamin A acid
Vitinoin
WLN: L6UTJ A1 B1U1Y1 & U2U1Y1 & U1VQ C1 C1
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U1VQ C1 C1
Zinc Salt, Tretinoin
[3H]Retinoic acid
all trans-Retinoic acid
all-(E)-Retinoic acid
all-(e)-Retinoic acid
all-trans-Retinoic acid
all-trans-Tretinoin
all-trans-Vitamin A acid
all-trans-Vitamin A1 acid
all-trans-Vitamin a acid
all-trans-Vitamin a1 acid
all-trans-b-Retinoic acid
all-trans-beta-Retinoic acid
b-Retinoic acid
beta all trans Retinoic Acid
beta-Ra
beta-Retinoic Acid
beta-Retinoic acid
beta-all-trans-Retinoic acid
bmse000562
nchembio.154-comp2
trans Retinoic Acid
trans-Retinoic acid
tretinoin
tretinoin liposome
tretinoine (French) (EINECS)
43Peripheral Nervous System AgentsPhase 3, Phase 2, Phase 123689
44Respiratory System AgentsPhase 3, Phase 1, Phase 24997
45Autonomic AgentsPhase 3, Phase 1, Phase 210150
46Clindamycin palmitatePhase 2, Phase 3172
47Clindamycin phosphatePhase 2, Phase 3172
48Vasoconstrictor AgentsPhase 3, Phase 1, Phase 22122
49Nasal DecongestantsPhase 3, Phase 1, Phase 2598
50Keratolytic AgentsPhase 2, Phase 3444

Interventional clinical trials:

(show top 50)    (show all 130)
idNameStatusNCT IDPhase
1Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on OraceaCompletedNCT01872715Phase 4
2MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.CompletedNCT02616250Phase 4
3Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular RosaceaCompletedNCT00855595Phase 4
4Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs PlaceboCompletedNCT01308619Phase 4
5Safety and Efficacy Study to Compare Two Rosacea Treatment RegimensCompletedNCT00495313Phase 4
6Efficacy of Topical Cyclosporin for Ocular RosaceaCompletedNCT00348335Phase 4
7ORCA - Oracea® for Rosacea: A Community-based AssessmentCompletedNCT00892281Phase 4
8Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot StudyCompletedNCT02147691Phase 4
9A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once DailyCompletedNCT00417937Phase 4
10Mirvaso in Use StudyCompletedNCT02249065Phase 4
11Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs PlaceboCompletedNCT01426269Phase 4
12Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single ApplicationCompletedNCT00436527Phase 4
13Photodynamic Therapy for Papulopustular RosaceaRecruitingNCT02075671Phase 4
14Internet Surveys and Their Impact on Adherence to Brimonidine Topical Gel and QOL in Patients With RosaceaRecruitingNCT02659670Phase 4
15Topical Brimonidine to Reduce Inflammation After IPL-treatment in Patients With Facial TelangiectasiasRecruitingNCT02761174Phase 4
16Intense Pulsed Light as an Adjunctive to Bromonidine for the Treatment of RosaceaNot yet recruitingNCT03053700Phase 4
17Oracea Soolantra Association in Patients With Severe RosaceaNot yet recruitingNCT03075891Phase 4
18Topical Timolol for the Treatment of Benign Vascular Periocular LesionsWithdrawnNCT01250457Phase 4
19Topical 0.5% Ivermectin Cream for Treatment of DemodicidosisUnknown statusNCT02036229Phase 3
20Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With RosaceaCompletedNCT01318733Phase 3
21Azelaic Acid on Demodex Counts in RosaceaCompletedNCT03035955Phase 2, Phase 3
22Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular RosaceaCompletedNCT01555463Phase 3
23Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With RosaceaCompletedNCT01355458Phase 3
24Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With RosaceaCompletedNCT01355471Phase 3
25Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne RosaceaCompletedNCT00041977Phase 3
26Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With RosaceaCompletedNCT02289352Phase 3
27A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial RosaceaCompletedNCT02120924Phase 3
28A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of RosaceaCompletedNCT02393937Phase 3
29Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat RosaceaCompletedNCT00823901Phase 2, Phase 3
30Isotretinoin in Papular-Pustular RosaceaCompletedNCT00882531Phase 3
31Phase 3 Papulopustular Rosacea StudyCompletedNCT01494467Phase 3
32Phase 3 Papulopustular Rosacea StudyCompletedNCT01493687Phase 3
33A Clinical Trial to Determine the Effects of 40 Mg Doxycycline Versus a Placebo Control for the Treatment of RosaceaCompletedNCT00126399Phase 3
34CD5024 1% [Ivermectin 1%] Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) StudyCompletedNCT01493947Phase 3
35Study of 0444 Gel in the Treatment of Inflammatory Lesions of RosaceaCompletedNCT01016782Phase 3
36A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With RosaceaCompletedNCT02095158Phase 3
37Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of RosaceaCompletedNCT01659853Phase 3
38Safety and Efficacy of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With RosaceaCompletedNCT02132117Phase 3
39Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema of RosaceaCompletedNCT01789775Phase 3
40Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of RosaceaCompletedNCT02795117Phase 3
41Comparative Safety and Efficacy of Two Rosacea Products in the Treatment of Facial Erythema of RosaceaCompletedNCT02385240Phase 3
42Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With RosaceaCompletedNCT02131636Phase 3
43Patient-Reported Outcome Of Facial Erythema (PROOF)CompletedNCT01885000Phase 3
44Clinical Endpoint Study of Ivermectin 1% CreamActive, not recruitingNCT02840461Phase 3
45Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the FaceActive, not recruitingNCT02800148Phase 3
46Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical GelActive, not recruitingNCT02576847Phase 3
47Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus VehicleActive, not recruitingNCT02576860Phase 3
48Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus VehicleActive, not recruitingNCT02547441Phase 3
49A Study to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam Compared to Vehicle in the Treatment of Facial Papulopustular RosaceaNot yet recruitingNCT03142451Phase 3
50Atralin Gel for the Treatment of RosaceaTerminatedNCT01125930Phase 3

Search NIH Clinical Center for Rosacea

Inferred drug relations via UMLS68/NDF-RT46:

Show with subtypes


Cochrane evidence based reviews: rosacea

Genetic Tests for Rosacea

About this section

Anatomical Context for Rosacea

About this section

MalaCards organs/tissues related to Rosacea:

36
Skin, Eye, Small intestine, B cells, Endothelial, Testes, Neutrophil

Publications for Rosacea

About this section

Articles related to Rosacea:

(show top 50)    (show all 667)
idTitleAuthorsYear
1
Risk of inflammatory bowel disease in patients with rosacea: Results from a nationwide cohort study in Taiwan. (28073582)
2017
2
The Role of Skin Care in Optimizing Treatment of Acne and Rosacea. (28492949)
2017
3
Development of Papulopustular Rosacea during Nivolumab Therapy of Metastatic Cancer. (27826614)
2016
4
Clinical assessment of rosacea severity: oriental score vs. quantitative assessment method with imaging and biomedical tools. (27514310)
2016
5
Facial Dermatitis and Rosacea. (27537212)
2016
6
Otophyma: a rare variant of phymatous rosacea. (27178518)
2016
7
A Randomized Controlled Trial of Omega 3 Fatty Acids in Rosacea Patients with Dry Eye Symptoms. (27050028)
2016
8
State of the art: systemic rosacea management. (27869374)
2016
9
Physical modalities for the treatment of rosacea. (27869377)
2016
10
Efficacy and safety of permethrin 5% topical gel vs. placebo for rosacea: a double-blind randomized controlled clinical trial. (27600257)
2016
11
Ocular acne rosacea in tertiary eye center in Saudi Arabia. (28039671)
2016
12
Association between rosacea and gastrointestinal disorders. (27603953)
2016
13
The relation of rosacea to insulin resistance and metabolic syndrome. (27026639)
2016
14
A case of Scalp Rosacea treated with low dose doxycycline and probiotic therapy and literature review on therapeutic options. (27087407)
2016
15
Clinical characteristics and epidermal barrier function of papulopustular rosacea: A comparison study with acne vulgaris. (28083023)
2016
16
Rosacea Management. (27843919)
2016
17
The role of small intestinal bacterial overgrowth in rosacea: A 3-year follow-up. (27543234)
2016
18
Comparative Efficacy of Radiofrequency and Pulsed Dye Laser in the Treatment of Rosacea. (27893539)
2016
19
Granulomatous rosacea-like facial eruption in an elderly man: leukaemia cutis. (27118756)
2016
20
Rosacea Management: Update on general measures and topical treatment options. (27869379)
2016
21
Recalcitrant steroid-induced rosacea successfully treated with 0.03% tacrolimus and 595-nm pulsed dye laser. (27193042)
2016
22
Monitoring structural changes in Demodex mites under topical Ivermectin in rosacea by means of reflectance confocal microscopy: a case series. (27976437)
2016
23
Rosacea fulminans or acute rosacea? Report of 5 cases and review of the literature. (27595202)
2016
24
Idiopathic Facial Aseptic Granuloma in a 13-Year-Old Boy Dramatically Improved with Oral Doxycycline and Topical Metronidazole: Evidence for a Link with Childhood Rosacea. (27920676)
2016
25
Rosacea and gastrointestinal disorders - a population-based cohort study. (27501017)
2016
26
TRPV4 mediates mast cell activation in cathelicidin-induced rosacea inflammation. (27908695)
2016
27
Rosacea: a Clinical Review. (27942368)
2016
28
Treatment of rosacea with topical ivermectin cream: a series of 34 cases. (27617938)
2016
29
Four Diseases, Two Associations, One Patient: A Case of Frontal Fibrosing Alopecia, Lichen Planus Pigmentosus, Acne Rosacea, and Morbihan Disease. (27502265)
2016
30
New developments in the treatment of rosacea - role of once-daily ivermectin cream. (27051311)
2016
31
Azathioprine-induced rosacea. (27997728)
2016
32
Low-Dose Isotretinoin: An OptionA forA Difficult-to-Treat Papulopustular Rosacea. (27212646)
2016
33
Clinical and Histologic Effects of Fractional Microneedling Radiofrequency Treatment on Rosacea. (27608206)
2016
34
Objective severity does not capture the impact of rosacea, acne scarring and photoaging in patients seeking laser therapy. (27640402)
2016
35
Two Consecutive Standardized Skin Surface Biopsies: An Improved Sampling Method to Evaluate Demodex Density as a Diagnostic Tool for Rosacea and Demodicosis. (27573185)
2016
36
Incidental focal epidermolytic hyperkeratosis in rosacea. (27401945)
2016
37
Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory Condition. (27649161)
2016
38
A systematic review and meta-analysis on Staphylococcus aureus carriage in psoriasis, acne and rosacea. (27151386)
2016
39
Drug-Induced Rosacea-like Dermatitis. (27149131)
2016
40
EGFRI-induced papulopustular rosacea-like rash successfully treated with topical ivermectin. (27988991)
2016
41
Canadian Clinical Practice Guidelines for Rosacea. (27207355)
2016
42
Sensitization to and allergic contact dermatitis caused by Mirvaso(Ar) (brimonidine tartrate) for treatment of rosacea - 2 cases. (27133629)
2016
43
Development of a core outcome set for clinical trials in rosacea: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey. (27580586)
2016
44
Pediatric rosacea. (27529708)
2016
45
Ivermectin 1% Cream (Soolantra) for Inflammatory Lesions of Rosacea. (27637130)
2016
46
Combination treatment of propranolol, minocycline, and tranexamic acid for effective control of rosacea. (27891741)
2016
47
Patient-reported outcomes of azelaic acid foam 15% for patients with papulopustular rosacea: secondary efficacy results from a randomized, controlled, double-blind, phase 3 trial. (27874885)
2016
48
Parkinson disease: New evidence for a pathogenic link between rosacea and Parkinson disease. (27063106)
2016
49
Successful treatment of rosacea fulminans in a 59-year-old woman with macrolide antibiotics and prednisone. (27028670)
2016
50
Pathogenesis and clinical presentation of rosacea as a key for a symptom-oriented therapy. (27869372)
2016

Variations for Rosacea

About this section

Expression for genes affiliated with Rosacea

About this section
Search GEO for disease gene expression data for Rosacea.

Pathways for genes affiliated with Rosacea

About this section

Pathways related to Rosacea according to GeneCards Suite gene sharing:

(show all 29)
idSuper pathwaysScoreTop Affiliating Genes
19.9MMP9, TLR2
2
Show member pathways
9.7MMP9, VEGFA
39.6TNF, VDR
49.3IL6, TNF
59.3IL6, TNF
69.3MMP9, PTGDR, VEGFA
7
Show member pathways
9.2MMP8, MMP9, TNF
89.2MMP9, TNF, VEGFA
9
Show member pathways
9.0IL6, TLR2, TNF
10
Show member pathways
9.0IL6, TLR2, TNF
11
Show member pathways
9.0IL6, TLR2, TNF
129.0IL6, TLR2, TNF
139.0IL6, TLR2, TNF
149.0IL6, TLR2, TNF
159.0IL6, TLR2, TNF
169.0IL6, MMP9, TNF
179.0IL6, MMP9, TNF
189.0IL6, MMP9, TNF
199.0IL6, MMP9, TNF
209.0IL6, TNF, VDR
218.9MMP9, TLR2, TNF, VEGFA
228.9IL6, TNF, VEGFA
238.9IL6, TNF, VEGFA
24
Show member pathways
8.7IL6, MMP9, TLR2, TNF
258.6IL6, TLR2, TNF, VEGFA
26
Show member pathways
8.6IL6, MMP9, TNF, VEGFA
278.6IL6, MMP9, TNF, VEGFA
288.4CAMP, IL6, TLR2, TNF, VDR
298.3IL6, MMP9, TLR2, TNF, VEGFA

GO Terms for genes affiliated with Rosacea

About this section

Cellular components related to Rosacea according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1tertiary granule lumenGO:19047249.5CAMP, MMP8, MMP9
2extracellular spaceGO:00056158.3CAMP, IL6, MMP8, MMP9, TNF, VEGFA

Biological processes related to Rosacea according to GeneCards Suite gene sharing:

(show all 20)
idNameGO IDScoreTop Affiliating Genes
1endodermal cell differentiationGO:003598710.5MMP8, MMP9
2macrophage differentiationGO:003022510.4MMP9, VEGFA
3negative regulation of growth of symbiont in hostGO:004413010.4CAMP, TNF
4positive regulation of interleukin-8 productionGO:003275710.4TLR2, TNF
5positive regulation of NF-kappaB import into nucleusGO:004234610.4TLR2, TNF
6positive regulation of protein complex assemblyGO:003133410.2TNF, VEGFA
7epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.1IL6, TNF
8negative regulation of lipid storageGO:001088810.1IL6, TNF
9neutrophil degranulationGO:00433129.9CAMP, MMP8, MMP9, TLR2
10positive regulation of protein phosphorylationGO:00019349.9MMP9, TNF, VEGFA
11cellular response to lipopolysaccharideGO:00712229.8CAMP, IL6, TNF
12positive regulation of chemokine productionGO:00327229.8IL6, TLR2, TNF
13positive regulation of interleukin-6 productionGO:00327559.8IL6, TLR2, TNF
14positive regulation of NF-kappaB transcription factor activityGO:00510929.7IL6, TLR2, TNF
15positive regulation of vascular smooth muscle cell proliferationGO:19047079.6MMP9, TNF
16positive regulation of peptidyl-serine phosphorylationGO:00331389.6IL6, TNF, VEGFA
17defense response to Gram-positive bacteriumGO:00508309.5CAMP, IL6, TLR2, TNF
18inflammatory responseGO:00069549.4IL6, PTGDR, TLR2, TNF
19positive regulation of gene expressionGO:00106289.0IL6, TLR2, TNF, VDR, VEGFA
20positive regulation of transcription from RNA polymerase II promoterGO:00459448.6IL6, TLR2, TNF, VDR, VEGFA

Sources for Rosacea

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet